GC 1107

Drug Profile

GC 1107

Alternative Names: GC1107; Td vaccine - Green Cross

Latest Information Update: 06 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Green Cross
  • Class Anti-infectives; Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Diphtheria; Tetanus

Most Recent Events

  • 17 Mar 2017 Registered for Diphtheria in South Korea (IM)
  • 17 Mar 2017 Registered for Tetanus in South Korea (IM)
  • 01 Oct 2014 Green Cross Corporation completes a phase III trial for Diphtheria and Tetanus (Prevention) in South Korea (NCT02361866)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top